Biogen Idec Undercuts Gilenya With $55,000 Yearly Price For Tecfidera
Executive Summary
The company expects dimethyl fumarate’s strong efficacy and favorable safety and tolerability profile to be an advantage against other oral multiple sclerosis drugs.